S&P 500

5.277,51

0,80%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Mountain Crest Acquisition Corporation V (MCAG)
Mountain Crest Acquisition Corporation V (MCAG) Notícias

MCAG

Mountain Crest Acquisiti... (MCAG)

Mountain Crest Acquisition Corporation V

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:MCAG

Data	Hora	Fonte	Título	Código	Companhia
02/05/2024	10:00	GlobeNewswire Inc.	CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
25/10/2023	10:00	GlobeNewswire Inc.	Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
20/06/2023	07:02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
20/06/2023	07:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
20/06/2023	07:01	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
12/06/2023	17:11	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
30/05/2023	09:00	GlobeNewswire Inc.	AUM Biosciences Doses First Patient in Phase 2 Clinical Trial of AUM001 in Metastatic Colorectal Cancer	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
24/05/2023	17:29	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
22/05/2023	07:02	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
15/05/2023	17:47	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
26/04/2023	18:23	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
26/04/2023	10:00	GlobeNewswire Inc.	AUM Biosciences to Participate in Inaugural EF Hutton Global Conference	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
14/02/2023	18:45	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
30/11/2022	10:00	GlobeNewswire Inc.	AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
25/11/2022	08:02	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
15/11/2022	10:00	GlobeNewswire Inc.	AUM Biosciences Receives Human Research Ethics Committee Approval to Commence Phase II Clinical Trial of AUM001 for Treatment of Metastatic Colorectal Cancer in Australia	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
04/11/2022	09:30	GlobeNewswire Inc.	AUM Biosciences to Participate in BioCentury-BayHelix East-West BioPharma Summit	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
21/10/2022	17:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
20/10/2022	06:00	GlobeNewswire Inc.	AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V
16/11/2021	19:30	GlobeNewswire Inc.	Mountain Crest Acquisition Corp. V Announces Closing of $60 Million Initial Public Offering	NASDAQ:MCAG	Mountain Crest Acquisition Corporation V